Summary & Overview
HCPCS C2630: Electrophysiology Diagnostic/Ablation Cool-Tip Catheter
HCPCS Level II code C2630 represents a cool-tip electrophysiology catheter used for diagnostic and ablation cardiac procedures when 3D or vector mapping is not used. This device-level code matters nationally because it identifies a specialized disposable device tied to high-cost cardiac electrophysiology services, affecting hospital supply budgeting, device utilization reporting, and payer coverage determinations. Key payers in national analyses include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for electrophysiology catheter use, typical sites of service, and the payer landscape relevant to device coding and coverage. The publication presents benchmarks and billing considerations, highlights potential policy updates that affect device reimbursement, and clarifies how C2630 fits into procedure service lines. Where input data is incomplete, statements note that specific taxonomy, ICD-10 linkage, and related-code details are not available. The content is intended to inform coding professionals, hospital finance teams, and policy analysts about the role and billing implications of HCPCS Level II code C2630 in national practice.
Billing Code Overview
HCPCS Level II code C2630 describes a diagnostic/ablation electrophysiology catheter configured as a cool-tip device and intended for procedures other than 3D or vector mapping. The service type is electrophysiology catheterization for diagnostic or ablation procedures. Typical sites of service for use of this device include hospital inpatient or outpatient cardiac catheterization labs and specialized electrophysiology procedure suites.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 67-year-old patient with symptomatic paroxysmal atrial fibrillation and recurrent palpitations is scheduled for an electrophysiology study with possible radiofrequency ablation. The patient has failed or is intolerant of at least one antiarrhythmic medication and is referred by the cardiologist for catheter-based mapping and targeted ablation of triggering foci. In the electrophysiology laboratory the patient undergoes vascular access (typically femoral venous), placement of diagnostic and ablation catheters, intracardiac electrogram recording, and programmed electrical stimulation. A cool-tip, non–3D-mapping ablation catheter (C2630) is used to deliver radiofrequency energy with irrigation to create controlled lesions. Typical monitoring includes continuous ECG, arterial pressure as indicated, and transesophageal echocardiography or intracardiac echocardiography when needed. The procedure is performed in an ambulatory surgical center or hospital cardiac catheterization/electrophysiology lab under monitored anesthesia care or general anesthesia depending on patient risk and procedural complexity. Post-procedure observation includes rhythm monitoring, vascular site assessment, and anticoagulation management per cardiology protocol prior to discharge or admission for overnight observation.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier | Standard reporting when no modifier applies |